BNKK · Bonk, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As of March 31, 2026, and December 31, 2025, the Company had $728,907 and $2,278,340 in cash, accumulated deficit of $185,320,822 and $183,492,179 and cash flow used in operations of $1,941,692 and $25,275,375, respectively. The Company has incurred and expects to continue to incur significant costs in pursuit of its expansion and development plans. These conditions raise doubt about the Company's ability to continue as a going concern and accordingly our auditors have included a going concern opinion in our annual report.”View the 10-Q filed May 13, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-13 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported is the weighted average price of multiple transactions. Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
9,000 |
| 2026-07-10 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported is the weighted average price of multiple transactions. Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
1,000 |
| 2026-07-02 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
11,659 |
| 2026-06-22 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
2,500 |
| 2026-06-22 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
2,500 |
| 2026-06-22 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
2,500 |
| 2026-06-16 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
2,500 |
| 2026-06-10 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.39 from June 10, 2026 to June 12, 2026. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
12,000 |
| 2026-04-09 | Rudy Mitchell Austin |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
Represents securities held by Nom Capital ULC in which the reporting person holds 100% equity interest. The reporting person has voting and investment power over all securities owned by Nom Capital ULC. |
Common Stock
(I)
|
31,055 |
| 2025-11-05 | Duffy Stacey Louise |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-12-11 | Melton Christopher |
Director |
Sell↓
|
Common Stock
|
3,470 |
| 2024-09-05 | Schur Jordan |
Director, President |
Award↑
Filing footnotes — Common Stock (Indirect)
The shares of common stock were issued to Core 4 Capital Corp. ("Core") under a securities purchase agreement dated as of August 30, 2024, including warrants to purchase shares of common stock which are immediately exercisable and will expire on August 29, 2029. The Reporting Person owns a 15% equity interest in Core, but does not have any investment or disposition power over any of the assets of Core. The Reporting Person disclaims ownership of all of the assets of Core. |
Common Stock
(I)
|
1,676,944 |
| 2024-09-05 | Schur Jordan |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The Shares were issued to the Reporting Person under the 2024 Equity Incentive Plan. |
Common Stock
|
250,000 |
| 2024-09-01 | Melton Christopher |
Director |
Convert↑
|
Common Stock
|
66,000 |
| 2024-09-01 | Melton Christopher |
Director |
Convert↓
Filing footnotes — Stock options (Right to buy) (Direct)
These options were granted to Mr. Melton pursuant to the Issuer's 2021 Incentive Equity Plan. The expiration date of the options were extended from 07/29/2022 to 12/31/2024 pursuant to a Board resolution. |
Stock options (Right to buy)
|
66,000 |
| 2024-07-08 | Schur Jordan |
Director, President |
Other↓
Filing footnotes — Common Stock (Direct)
The Reporting Person gifted the shares of common stock to certain individuals. |
Common Stock
|
250,000 |
| 2024-06-28 | Schur Jordan |
Director, President |
Award↑
Filing footnotes — Common Stock (Indirect)
The shares of common stock were issued to Core 4 Capital Corp ("Core") under a securities purchase agreement dated June 27, 2024, entered into by and between the Issuer and Core. The Reporting Person owns 15% equity interest in Core. The Reporting Person disclaims ownership of all but 15% of the shares owned by Core in accordance with his ownership percentage of Core. |
Common Stock
(I)
|
943,396 |
| 2024-06-14 | Schur Jordan |
Director, President |
Award↑
Filing footnotes — Common Stock (Direct)
The shares of common stock were issued to the Reporting Person under the Issuer's Equity Incentive Plan. |
Common Stock
|
250,000 |
| 2024-03-08 | LONG DAVID J III |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2024-03-01 | WILSON GLYNN |
Director, Chief Executive Officer |
Other↑
Filing footnotes — Stock Options (Direct)
The options have an exercise price ranging between $0.84 to $1.30. The options were disposed of, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, John Gulyus, Brian John, and Safety Shot, Inc. |
Stock Options
|
1,900,000 |
| 2024-03-01 | Boon Jarrett Adam |
Director, CEO |
Award↑
Filing footnotes — Stock Options (Direct)
The options have an exercise price ranging between $0.84 to $1.30. The options were acquired, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Glynn Wilson, John Gulyus, Brian John, and Safety Shot, Inc. |
Stock Options
|
1,900,000 |
| 2024-03-01 | Gulyas John |
Director |
Award↑
Filing footnotes — Stock Options (Direct)
The options have an exercise price ranging between $0.84 to $1.30. The options were acquired, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, Glynn Wilson, Brian John, and Safety Shot, Inc. |
Stock Options
|
1,900,000 |
| 2024-03-01 | John Brian |
Director |
Other↑
Filing footnotes — Stock Options (Direct)
The options have an exercise price ranging between $0.84 to $1.30. The options were disposed of, for an aggregate price of $190,000, under an omnibus agreement entered into by and among the Reporting Person, Jarrett Boon, John Gulyus, Glynn Wilson, and Safety Shot, Inc. |
Stock Options
|
1,900,000 |
| 2023-12-29 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with a per share price of $3.50. |
Common stock
|
3,000 |
| 2023-12-28 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with a per share price of $3.88. |
Common stock
|
2,500 |
| 2023-08-31 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Indirect)
On August 31, 2023, GBB Beverage, Inc. ("GBB") acquired 5,000,000 shares of the Issuer in exchange for certain assets of GBB. Mr. Gulyas is the owner of 33.33% of the capital stock of GBB and as such is deemed to be the beneficial owner of 1,666,666 shares of the 5,000,000 shares of common stock owned by GBB. |
Common stock
(I)
|
1,666,666 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
200 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
500 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
500 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
2,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
2,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
3,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
3,000 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
300 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
500 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
500 |
| 2023-08-07 | Gulyas John |
Director |
Buy↑
Filing footnotes — Common stock (Direct)
The Shares were bought in open market with an average price of $0.775. |
Common stock
|
1,000 |
| 2023-07-17 | Gulyas John |
Director |
Other↑
|
No Securities Owned
|
0 |
| 2022-12-30 | FANI SKENDER |
Director |
Award↑
Filing footnotes — Stock options (Right to buy) (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock options (Right to buy)
|
50,000 |
| 2022-12-30 | John Brian |
Director |
Award↑
Filing footnotes — Stock options (Right to buy) (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.83600 based on 110% of the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock options (Right to buy)
|
1,050,000 |
| 2022-12-30 | MCKINNON DOUGLAS O |
CFO |
Award↑
Filing footnotes — Stock Options (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock Options
|
500,000 |
| 2022-12-30 | WILSON GLYNN |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Options (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock Options
|
1,050,000 |
| 2022-12-30 | Torres Kaufman Nancy |
Director |
Award↑
Filing footnotes — Stock options (Right to buy) (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock options (Right to buy)
|
50,000 |
| 2022-12-30 | Melton Christopher |
Director |
Award↑
Filing footnotes — Stock options (Right to buy) (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock options (Right to buy)
|
50,000 |
| 2022-12-30 | Alila Hector W |
Director |
Award↑
Filing footnotes — Stock options (Right to buy) (Direct)
The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Stock options (Right to buy)
|
50,000 |